Displaying 1 - 6 of 6
| Active Ingredient | HYPOTENSIVE AGENTS |
| Therapeutic Class | HYPOTENSIVE AGENTS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | AMLODIPINE | CHLORTHALIDONE |
| Therapeutic Class | HYPOTENSIVE AGENTS, MISCELLANEOUS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | AMLODIPINE | INDAPAMIDE |
| Therapeutic Class | HYPOTENSIVE AGENTS, MISCELLANEOUS |
| Indications | Hypertension in patients stabilised on the individual components. |
| Caution | As for amlodipine, indapamide. |
| Dose Range | In hypertension, the usual dose is 1.5mg\5mg once daily, increasing if necessary to 1.5mg\10mg once daily. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | AMLODIPINE | TELMISARTAN |
| Therapeutic Class | HYPOTENSIVE AGENTS, MISCELLANEOUS |
| Indications | Treatment of mild to moderate hypertension. |
| Caution | Peripheral edema, dizziness and back pain. Edema (other than peripheral edema), hypotension, and syncope were reported, in a study which evaluated the concomitant use of Telmisartan and Amlodipine More ... |
| Dose Range | In hypertension the usual initial dose is 5 mg/80mg once daily, increased, if necessary, to 10mg/80mg once daily. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | AMLODIPINE | VALSARTAN |
| Therapeutic Class | HYPOTENSIVE AGENTS, MISCELLANEOUS |
| Indications | Hypertension in patients stabilised on the individual components. |
| Caution | As for amlodipine, valsartan. |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | RILMENIDINE |
| Therapeutic Class | HYPOTENSIVE AGENTS, MISCELLANEOUS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |